Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 16, 2008

IDT Inks Probe Manufacturing License with Applied Biosystems

  • Integrated DNA Technologies (IDT) obtained a probe manufacturing license from Applied Biosystems to sell dual-labeled probes for use in the 5’ Nuclease process, a technique for real-time PCR.

    The license will make it possible for IDT to offer design services for probes and primers for use in the assay and to supply researchers with the resulting probes and primers in a more convenient, ready-to-use format, according to the firms.

    Customers will thus be able to purchase probes from IDT that are licensed for use in the 5’ Nuclease Assay. Currently, researchers purchase probes and primers in separate tubes, and often from separate vendors that disclaim any licensed right of the customer to use the probes in the 5’ Nuclease Assay.

    Applied Biosystems’ probe manufacturing license program grants licensees rights to make and sell custom oligonucleotides and oligonucleotide sets for use in the 5’ Nuclease process under patents owned by both Applied Biosystems and Roche.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »